In preclinical animal models of invasive pneumonia, curcumin modulates pro- and anti-inflammatory factors (COX-2, IL-6, IL-8, and IL-10), induces apoptosis in polymorphonuclear neutrophilic cells, and mitigates ROS damage (235). Here, IL6 is linked to pneumonia.